Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation

Biological Chemistry

Volumn 393, Issue 8, 2012, Pages 785-799

  Storck, Wiebke ^a   Meisen, Iris ^a   Gianmoena, Kathrin ^a   Pläger, Ina ^a   Kouzel, Ivan U ^a   Bielaszewska, Martina ^a   Haier, Jörg ^b   Mormann, Michael ^a   Humpf, Hans Ulrich ^a   Karch, Helge ^a   Müthing, Johannes ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Gb3Cer; Gb4Cer; Glycolipids; Mass spectrometry; Metastases; Tumor

Indexed keywords

GLOBOTETRAOSYLCERAMIDE; GLYCOSPHINGOLIPID; SHIGA TOXIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL LINE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THIN LAYER CHROMATOGRAPHY;

ADENOCARCINOMA; ASCITES; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLOBOSIDES; HUMANS; LIVER NEOPLASMS; LYMPH NODES; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; TRIHEXOSYLCERAMIDES;

EID: 84867798179     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0165     Document Type: Article

References (79)

1. Adams, J. and Ann, Q. (1993). Structure determination of sphingolipids by mass spectrometry. Mass Spectrom. Rev. 12, 51 -85.
2. Arab, S., Murakami, M., Dirks, P., Boyd, B., Hubbard, S.L., Lingwood, C.A., and Rutka, J.T. (1998). Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells. J. Neurooncol. 40, 137 -150.
3. Arab, S., Rutka, J., and Lingwood, C. (1999). Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. Oncol. Res. 11, 33 -39.
4. Bauwens, A., Bielaszewska, M., Kemper, B., Langehanenberg, P., von Bally, G., Reichelt, R., Mulac, D., Humpf, H.U., Friedrich, A.W., Kim, K.S., et al. (2011). Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb. Haemost. 105, 515 -528.
5. Betz, J., Bielaszewska, M., Thies, A., Humpf, H.U., Dreisewerd, K., Karch, H., Kim, K.S., Friedrich, A.W., and Müthing, J. (2011). Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains. J. Lipid Res. 52, 618 -634.
6. Betz, J., Bauwens, A., Kunsmann, L., Bielaszewska, M., Mormann, M., Humpf, H.U., Karch, H., Friedrich, A.W., and Müthing, J. (2012). Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells. Biol. Chem. 393, 133 -147.
7. Bielaszewska, M. and Karch, H. (2005). Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb. Haemost. 94, 312 -318.
8. Chester, M.A. (1999). IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids. Recommendations 1997. Glycoconj. J. 16, 1 -6.
9. Distler, U., Souady, J., Hülsewig, M., Drmić -Hofman, I., Haier, J., Friedrich, A.W., Karch, H., Senninger, N., Dreisewerd, K., Berkenkamp, S., et al. (2009). Shiga toxin receptor Gb3Cer/ CD77: tumor association and promising therapeutic target in pancreas and colon cancer. PLoS One 4, e6813.
10. Domon, B. and Costello, C.E. (1988a). A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj. J. 5, 397 -409.
11. Domon, B. and Costello, C.E. (1988b). Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry 27, 1534 -1543.
12. Engedal, N., Skotland, T., Torgersen, M.L., and Sandvig, K. (2011). Shiga toxin and its use in targeted cancer therapy and imaging. Microb. Biotechnol. 4, 32 -46.
13. Falguières, T., Mallard, F., Baron, C., Hanau, D., Lingwood, C., Goud, B., Salamero, J., and Johannes, L. (2001). Targeting of Shiga toxin B subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 12, 2453 -2468.
14. Falguières, T., Maak, M., von Weyhern, C., Sarr, M., Sastre, X., Poupon, M.F., Robine, S., Johannes, L., and Janssen, K.P. (2008). Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol. Cancer Ther. 7, 2498 -2508.
15. Farkas-Himsley, H., Hill, R., Rosen, B., Arab, S., and Lingwood, C.A. (1995). The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc. Natl. Acad. Sci. USA 92, 6996 -7000.
16. Feizi, T. (1985). Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are oncodevelopmental antigens. Nature 314, 53 -57.
17. Friedrich, A.W., Bielaszewska, M., Zhang, W., Pulz, M., Kuczius, T., Ammon, A., and Karch, H. (2002). Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185, 74 -84.
18. Gariépy, J. (2001). The use of Shiga-like toxin 1 in cancer therapy. Crit. Rev. Oncol. Hematol. 39, 99 -106.
19. Gupta, G. and Surolia, A. (2010). Glycosphingolipids in microdomain formation and their spatial organization. FEBS Lett. 584, 1634 -1641.
20. Hakomori, S. (1996). Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56, 5309 -5318.
21. Hakomori, S.I. (2008). Structure and function of glycosphingo lipids and sphingolipids: recollections and future trends. Biochim. Biophys. Acta 1780, 325 -346.
22. Hoffmann, P., Hülsewig, M., Duvar, S., Ziehr, H., Mormann, M., Peter-Katalinić, J., Friedrich, A.W., Karch, H., and Müthing, J. (2010). On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 24, 2295 -2304.
23. Hotz, B., Backer, M.V., Backer, J.M., Buhr, H.J., and Hotz, H.G. (2010). Specific targeting of tumor endothelial cells by Shigalike toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer. Neoplasia 12, 797 -806.
24. Iwabuchi, K., Nakayama, H., Iwahara, C., and Takamori, K. (2010). Significance of glycosphingolipid fatty acid chain length on membrane microdomain-mediated signal transduction. FEBS Lett. 584, 1642 -1652.
25. Janssen, K.P., Vignjevic, D., Boisgard, R., Falguières, T., Bousquet, G., Decaudin, D., Dollé, F., Louvard, D., Tavitian, B., Robine, S., et al. (2006). In vivo tumor targeting using a novel intestinal pathogen-based delivery approach. Cancer Res. 66, 7230 -7236.
26. Johannes, L. and Römer, W. (2010). Shiga toxins -from cell biology to biomedical applications. Nat. Rev. Microbiol. 8, 105 -116.
27. Johansson, D., Johansson, A., Grankvist, K., Andersson, U., Henriksson, R., Bergström, P., Brännström, T., and Behnam-Motlagh, P. (2006). Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biol. Ther. 5, 1211 -1217.
28. Johansson, D., Kosavac, E., Moharer, J., Ljuslinder, I., Brännström, T., Johansson, A., and Behnam-Motlagh, P. (2009). Expression of verotoxin-I receptor Gb3 in breast cancer tissue and verotoxin-I signal transduction to apoptosis. BMC Cancer 9, 67.
29. Kannagi, R., Yin, J., Miyazaki, K., and Izawa, M. (2008). Current relevance of incomplete synthesis and neo-synthesis for cancerassociated alteration of carbohydrate determinants -Hakomori's concepts revisited. Biochim. Biophys. Acta 1780, 525 -531.
30. Karlsson, K.A. (1989). Animal glycosphingolipids as membrane attachment sites for bacteria. Annu. Rev. Biochem. 58, 309 -350.
31. Kiguchi, K., Iwamori, Y., Suzuki, N., Kobayashi, Y., Ishizuka, B., Ishiwata, I., Kita, T., Kikuchi, Y., and Iwamori, M. (2006). Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. Cancer Sci. 97, 1321 -1326.
32. Kovbasnjuk, O., Edidin, M., and Donowitz, M. (2001). Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J. Cell Sci. 114, 4025 -4031.
33. Kovbasnjuk, O., Mourtazina, R., Baibakov, B., Wang, T., Elowsky, C., Choti, M.A., Kane, A., and Donowitz, M. (2005). The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc. Natl. Acad. Sci. USA 102, 19087 -19092.
34. LaCasse, E.C., Bray, M.R., Patterson, B., Lim, W.M., Perampalam, S., Radvanyi, L.G., Keating, A., Stewart, A.K., Buckstein, R., Sandhu, J.S., et al. (1999). Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34 + hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. Blood 94, 2901 -2910.
35. Ledeen, R.W. and Yu, R.K. (1982). Gangliosides: structure, isolation, and analysis. Methods Enzymol. 83, 139 -191.
36. Lencer, W.I. and Saslowsky, D. (2005). Raft trafficking of AB 5 subunit bacterial toxins. Biochim. Biophys. Acta 1746, 314 -321.
37. Levery, S.B. (2005). Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405, 300 -369.
38. Lingwood, C.A. (1996). Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4, 147 -153.
39. Lingwood, C.A., Manis, A., Mahfoud, R., Khan, F., Binnington, B., and Mylvaganam, M. (2010a). New aspects of the regulation of glycosphingolipid receptor function. Chem. Phys. Lipids 163, 27 -35.
40. Lingwood, C.A., Binnington, B., Manis, A., and Branch, D.R. (2010b). Globotriaosyl ceramide receptor function -where membrane structure and pathology intersect. FEBS Lett. 584, 1879 -1886.
41. Lingwood, D., Binnington, B., Róg, T., Vattulainen, I., Grzybek, M., Coskun, Ü ., Lingwood, C.A., and Simons, K. (2011). Cholesterol modulates glycolipid conformation and receptor activity. Nat. Chem. Biol. 7, 260 -262.
42. Lopez, P.H.H. and Schnaar, R. (2009). Gangliosides in cell recognition and membrane protein regulation. Curr. Opin. Struct. Biol. 19, 549 -557.
43. Maak, M., Nitsche, U., Keller, L., Wolf, P., Sarr, M., Thiebaud, M., Rosenberg, R., Langer, R., Kleeft, J., Friess, H., et al. (2011). Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunit. Mol. Cancer Ther. 10, 1918 -1928.
44. Mahfoud, R., Manis, A., Binnington, B., Ackerley, C., and Lingwood, C.A. (2010). A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins. J. Biol. Chem. 285, 36049 -36059.
45. Mees, S.T., Mardin, W.A., Wendel, C., Baeumer, N., Willscher, E., Senninger, N., Schleicher, C., Colombo-Benkmann, M., and Haier, J. (2010). EP300 -a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int. J. Cancer 126, 114 -124.
46. Mees, S.T., Schleicher, C., Mardin, W.A., Senninger, N., Colombo-Benkmann, M., and Haier, J. (2011). Analyzing miRNAs in ductal adenocarcinomas of the pancreas. J. Surg. Res. 169, 241 -246.
47. Meisen, I., Peter-Katalinić, J., and Müthing, J. (2003). Discrimination of neolacto-series gangliosides with α 2-3-and α 2-6-linked N -acetylneuraminic acid by nanoelectrospray ionization lowenergy collision-induced dissociation tandem quadrupole TOF MS. Anal. Chem. 75, 5719 -5725.
48. Meisen, I., Peter-Katalinić, J., and Müthing, J. (2004). Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry. Anal. Chem. 76, 2248 -2255.
49. Meisen, I., Friedrich, A.W., Karch. H., Witting, U., Peter- Katalinić, J., and Müthing, J. (2005). Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high-and lowaffinity binding ligands of Shiga toxin 1. Rapid Commun. Mass Spectrom. 19, 3659 -3665.
50. Meisen, I., Mormann, M., and Müthing, J. (2011). Thin-layer chromatography, overlay technique and mass spectrometry: a versatile triad advancing glycosphingolipidomics. Biochim. Biophys. Acta 1811, 875 -896.
51. Merrill, Jr., A.H. (2011). Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 111, 6387 -6422.
52. Middleton, G., Ghaneh, P., Costello, E., Greenhalf, W., and Neoptolemos, J.P. (2008). New treatment options for advanced pancreatic cancer. Expert Rev. Gastroenterol. Hepatol. 2, 673 -696.
53. Müthing, J. (1998). TLC in structure and recognition studies of glycosphingolipids. In: Methods in Molecular Biology, E.F. Hounsell, ed. (Totowa, NJ: Humana Press), pp. 183-195.
54. Müthing, J. and Distler, U. (2010). Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. Mass Spectrom. Rev. 29, 425 -479.
55. Müthing, J., Egge, H., Kniep, B., and Mühlradt, P.F. (1987). Structural characterization of gangliosides from murine T lymphocytes. Eur. J. Biochem. 163, 407 -416.
56. Müthing, J., Kemminer, S.E., Conradt, H.S., Šagi, D., Nimtz, M., Kärst, U., and Peter-Katalinić, J. (2003). Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. Biotechnol. Bioeng. 83, 321 -334.
57. Müthing, J., Schweppe, C.H., Karch, H., and Friedrich, A.W. (2009). Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 101, 252 -264.
58. Müthing, J., Meisen, I., Zhang, W., Bielaszewska, M., Mormann, M., Bauerfeind, R., Schmidt, M.A., Friedrich, A.W., and Karch, H. (2012). Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. Glycobiology 22, 849-862.
59. Nakajima, H., Kiyokawa, N., Katagiri, Y.U., Taguchi, T., Suzuki, T., Sekino, T., Mimori, K., Ebata, T., Saito, M., Nakao, H., et al. (2001). Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J. Biol. Chem. 276, 42915 -42922.
60. Prinetti, A., Loberto, N., Chigorno, V., and Sonnino, S. (2009). Glycosphingolipids behaviour in complex membranes. Biochim. Biophys. Acta 1788, 184 -193.
61. Römer, W., Berland, L., Chambon, V., Gaus, K., Windschiegl, B., Tenza, D., Aly, M.R.E., Fraisier, V., Florent, J.C., Perrais, D., et al. (2007). Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 450, 670 -675.
62. Safouane, M., Berland, L., Callan-Jones, A., Sorre, B., Römer, W., Johannes, L., Toombes, G.E.S., and Bassereau, P. (2010). Lipid cosorting mediated by Shiga toxin induced tubulation. Traffic 11, 1519 -1529.
63. Salhia, B., Rutka, J.T., Lingwood, C., Nutikka, A., and van Furth, W.R. (2002). The treatment of malignant meningioma with verotoxin. Neoplasia 4, 304 -311.
64. Sandvig, K. (2001). Shiga toxins. Toxicon 39, 1629 -1635.
65. Sandvig, K., Bergan, J., Dyve, A.B., Skotland, T., and Torgersen, M.L. (2010a). Endocytosis and retrograde transport of Shiga toxin. Toxicon 56, 1181 -1185.
66. Sandvig, K., Torgersen, M.L., Engedal, N., Skotland, T., and Iversen, T.G. (2010b). Protein toxins from plants and bacteria: Probes for intracellular transport and tools in medicine. FEBS Lett. 584, 2626 -2634.
67. Schweppe, C.H., Bielaszewska, M., Pohlentz, G., Friedrich, A.W., Büntemeyer, H., Schmidt, M.A., Kim, K.S., Peter-Katalinić, J., Karch, H., and Müthing, J. (2008). Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/ CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. Glycoconj. J. 25, 291 -304.
68. Schweppe, C.H., Hoffmann, P., Nofer, J.R., Pohlentz, G., Mormann, M., Karch, H., Friedrich, A.W., and Müthing, J. (2010). Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors. J. Lipid Res. 51, 2282 -2294.
69. Sens, P., Johannes, L., and Bassereau, P. (2008). Biophysical approaches to protein-induced membrane deformations in trafficking. Curr. Opin. Cell Biol. 20, 476-482.
70. Siegel, R., Naishadham, D., and Jemal, A. (2012). Cancer statistics, 2012. CA Cancer J. Clin. 62, 10 -29.
71. Smith, D.C., Lord, J.M., Roberts, L.M., and Johannes, L. (2004). Glycosphingolipids as toxin receptors. Semin. Cell Dev. Biol. 15, 397 -408.
72. Smith, D.C., Sillence, D.J., Falguières, T., Jarvis, R.M., Johannes, L., Lord, J.M., Platt, F.M., and Roberts, L.M. (2006). The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell. 17, 1375-1387.
73. Sonnino, S. and Prinetti, A. (2009). Sphingolipids and membrane environments for caveolin. FEBS Lett. 583, 597 -606.
74. Sonnino, S., Prinetti, A., Nakayama, H., Yangida, M., Ogawa, H., and Iwabuchi, K. (2009). Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils. Glycoconj. J. 26, 615 -621.
75. Tarr, P.I., Gordon, C.A., and Chandler, W.L. (2005). Shiga-toxinproducing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073 -1086.
76. Todeschini, A.R. and Hakomori, S.I. (2008). Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta 178 0, 421 -433.
77. Vaccaro, V., Melisi, D., Bria, E., Cuppone, F., Ciuffreda, L., Pino, M.S., Gelibter, A., Tortora, G., Cognetti, F., and Milella, M. (2011). Emerging pathways and future targets for the molecular therapy of pancreatic cancer. Expert Opin. Ther. Targets 15, 1183-1196.
78. Yu, R.K., Nakatani, Y., and Yanagisawa, M. (2009). The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 50, S440 -S445.
79. Zar, J.H. (1972). Significance testing of the Spearman rank correlation. J. Am. Statist. Assoc. 67, 578 -580.